Surfacer System to Facilitate Access in Venous Occlusions

Merit Medical Systems, Inc.30 enrolled

Overview

Prospective, single-arm, multicentre, international Registry of the Surfacer System for the treatment of patients with limited or diminishing upper body venous access or pathology impeding standard access methods.The purpose of this post-market Registry is to assess the standard of care and clinical outcomes of the Surfacer System used in clinical routine according to the approved commercial indications.

This is a prospective, single-arm, multicenter registry of the Surfacer System for patients with limited or diminishing upper body venous access or pathology impeding standard access methods. The need for long term access and lack of availability of veins has led to the development of the Surfacer System, which facilitates reliable and repeatable placement of central venous catheters and restores central venous access. Based on European legislation, this Registry is considered to be an observational study. No additional diagnostic or monitoring procedures as a result of the inclusion are applied to the patients. Available data will be collected in a protected database. Up to 30 patients will be enrolled in 5 sites in Europe. Patients requiring central venous access will be enrolled who meet inclusion and exclusion criteria and for whom the device is indicated.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Chronic Venous Thrombosis Venous Thrombosis Upper Extremity Venous Thrombosis Upper Extremity Superficial Veins

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: patients referred for placement of a central venous catheter * patients with limited or diminishing upper body venous access * pathology impeding standard access methods * signed informed consent Exclusion Criteria: * vulnerable subjects or incapable of giving consent * contraindications to central venous access based on treating physicians opinion or standard of care * occlusion of the right femoral vein * occlusion of the iliac vein * occlusion of the inferior vena * acute thrombosis within a vessel (IVC, brachiocephalic and subclavian)

Locations (4)

University of Vienna

Vienna, Waehringer Guertel 18-20, Austria

University Hospital of Cologne

Cologne, Germany

Schon Klinik

Düsseldorf, Germany

Azienda Ospedaliera San Carlo Borromeo

Milan, Italy

Outcomes

Primary Outcomes

Absence of all acute safety and device related serious adverse event recorded on case report forms

overall complication rate compared to safety data

Time frame: Procedure through discharge at 24 hours post procedure. Data will be presented through study completion, 1 year.

Secondary Outcomes

Ability to place central venous access catheter using Surfacer system

performance evaluated by procedure time measured by time to create access

Time frame: Procedure

Surfacer system advancement of the exit wire outside the vein

Ability to advance system from femoral vein to supraclavicular exit as measured by time

Time frame: procedure

Insertion of a standard central venous access catheter to deliver fluid or pharmacological agents

introducing a standard central venous access catheter over the needle wire

Time frame: procedure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.